Editorial Board

Vaccines & Vaccination Open Access

Home VVOA Editorial Board Ishtiaq Qadri

Share this profile

LinkedIn Twitter / X

✓ Link copied!

Ishtiaq Qadri

Ishtiaq Qadri

Editorial Board Member
King Abdul Aziz University Saudi Arabia Member since 2016

Biography

Ishtiaq Qadri is a Professor at the King Abdul Aziz University, Jeddah, Saudi Arabia where his research is focused on the broad areas of viral hepatitis and associated hepatocarcinoma. He has also been enthusiastically involved in the study of liver adaptive responses, specific gene expression and regulation during insulin resistance, hepatic steatosis, type -2 diabetes b in the context of viral infection. He is heading a group of energetic and vibrant scientists from multidisciplinary background under Medical Biotechnology/Translational Research group to cover many areas of investigation for the ultimate control of viral induced diseases, antiviral and vaccine. The in vitro cell based, -animal models and cancer stems cells are employed to conduct research and produce pharmaceutical and diagnostic products for prevention of human diseases is the primary goal of this group. He was invited by the Higher Education Commission of Pakistan as foreign faculty professor where he conceived the idea to establish a national research center (NCVI) for the control and ultimate eradication of key viral diseases in Pakistan (2007-12). He has served with various key capacitates in many internationals settings in UK, USA, Pakistan and Saudi Arabia (1983-2015). He is the recipient of over 28 international Research and Development grants (R & D) covering numerous areas of investigations which were funded from the National Institute of Health USA, American Liver Foundation, Colorado League of Cancer, US-State Dept, Bio-Safety Engagement Program of US, Pasteur Institute of France, Higher Education Commission, Ministry of Science and Technology of Pakistan and Pakistan Science Foundation and KACST, Riyadh, Saudi Arabia. The ongoing research activities involve diverse sciences such as genomics, recombinant gene technologies, molecular immunology and development of pharmaceutical therapies and biomarkers development for prognostic & diagnostic tools.

Research Interests

viral hepatitis antiviral vaccines

Other Editorial Board Members

Submit Manuscript

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?